{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.008, "earningsTimestamp": 1682640040, "earningsTimestampStart": 1682640040, "earningsTimestampEnd": 1682640040, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.01, "epsForward": -0.07, "epsCurrentYear": -0.07, "priceEpsCurrentYear": -0.11428572, "sharesOutstanding": 3349690112, "bookValue": -0.001, "fiftyDayAverage": 0.00894, "fiftyDayAverageChange": -0.0009399997, "fiftyDayAverageChangePercent": -0.10514538, "twoHundredDayAverage": 0.012495, "twoHundredDayAverageChange": -0.0044949995, "twoHundredDayAverageChangePercent": -0.35974386, "marketCap": 26797522, "forwardPE": -0.11428572, "priceToBook": -8.0, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "averageAnalystRating": "1.0 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1166655600000, "priceHint": 4, "marketState": "POSTPOST", "exchange": "ASX", "shortName": "MGC PHARMA FPO", "longName": "MGC Pharmaceuticals Limited", "messageBoardId": "finmb_146284473", "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "market": "au_market", "esgPopulated": false, "regularMarketChange": 0.0, "regularMarketTime": 1683871827, "regularMarketDayHigh": 0.008, "regularMarketDayRange": "0.007 - 0.008", "regularMarketDayLow": 0.007, "regularMarketVolume": 1774469, "regularMarketPreviousClose": 0.008, "bid": 0.007, "ask": 0.008, "bidSize": 0, "askSize": 0, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 0.008, "averageDailyVolume3Month": 2609960, "averageDailyVolume10Day": 2327670, "fiftyTwoWeekLowChange": 0.0010000002, "fiftyTwoWeekLowChangePercent": 0.14285716, "fiftyTwoWeekRange": "0.007 - 0.024", "fiftyTwoWeekHighChange": -0.015999999, "fiftyTwoWeekHighChangePercent": -0.6666666, "fiftyTwoWeekLow": 0.007, "fiftyTwoWeekHigh": 0.024, "symbol": "MXC.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1202 Hay Street", "city": "West Perth", "state": "WA", "zip": "6005", "country": "Australia", "phone": "61 8 6382 3390", "fax": "61 8 9389 2099", "website": "https://mgcpharma.com.au", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Roby Reuven Zomer", "age": 42, "title": "Co-Founder, CEO, MD & Exec. Director", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": {"raw": 484632, "fmt": "484.63k", "longFmt": "484,632"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tom  Cairns", "title": "Chief Accounting Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Yifat  Steuer", "title": "Deputy CEO & COO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Nicole Ann Godresse", "title": "Global Chief Sales Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Amir  Polak", "title": "Chief Pharmaceutical Devel. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sabina  Suljakovic", "title": "Head of the Quality Assurance Department", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nadya  Lisovoder", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sasha  Friedman", "title": "Deputy CEO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Yair  Tal", "title": "Chief Information Security Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert  Clements", "title": "Chief Commercial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}